Peroral versus intravenous post-operative antibiotics after surgery for complicated appendicitis: protocol for a cluster-randomised cluster-crossover non-inferiority study

Dan Med J. 2021 May 28;68(6):A12200917.

Abstract

Introduction: Complicated appendicitis increases the risk of post-operative intra-abdominal abscess. Treatment of complicated appendicitis is usually a post-operative course of intravenous antibiotics. A study is needed to confirm the results of retrospective studies showing that a post-operative course of oral antibiotics is not inferior to intravenous antibiotics after laparoscopic surgery for complicated appendicitis.

Methods: The Per oral versus Intravenous Postoperative Antibiotics after surgery for complicated appendicitis (PIPA) trial will be a prospective, multicentre, cluster-randomised cluster-crossover non-inferiority study designed to test whether a three-day post-operative course of oral antibiotics is non-inferior to a three-day post-operative course of intravenous antibiotics as standard care after laparoscopic surgery for complicated appendicitis in regards to the risk of post-operative intra-abdominal abscess formation within 30 days. Participating hospitals will either be randomised to a six-month period with an oral antibiotic regime followed by a six-month period with an intravenous antibiotic regime for the post-operative treatment after laparoscopic surgery for complicated appendicitis, or to a six-month period with an intravenous antibiotic regime followed by a six-month period with an oral antibiotic regime for post-operative treatment after laparoscopic surgery for complicated appendicitis.

Conclusions: The primary outcome will be the incidence of intra-abdominal abscess by post-operative day 30.

Funding: none.

Trial registration: The study was approved by the Danish Data Protection Agency and by the National/Regional Committee on Health Research Ethics.

Publication types

  • Clinical Trial Protocol

MeSH terms

  • Abdominal Abscess* / drug therapy
  • Anti-Bacterial Agents / therapeutic use
  • Appendectomy / adverse effects
  • Appendicitis* / drug therapy
  • Appendicitis* / surgery
  • Cross-Over Studies
  • Equivalence Trials as Topic
  • Humans
  • Multicenter Studies as Topic
  • Prospective Studies
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents